CODA Medical Director Melissa Weimer was asked by KGW newsman Wayne Havrelly about the threat of “krokodil,” a potent drug turning up in some U.S. cities. The drug, reports Havrelly,
As Portland Business Journal writer Sean Meyers reports in the Sept. 13 issue: Two of Portland’s biggest names in healthcare formed a partnership that has been awarded the Portland Business Journal’s “Innovation in Philanthropy
Melissa Weimer, DO, MCR, who has provided clinical services at CODA for the past two years, has joined the agency as Medical Director. Dr. Weimer also serves as an Assistant
CODA research staff is a co-author of a recent publication, “Treatment Retention among Patients Randomized to Buprenorphine/Naloxone Compared to Methadone in a Multi-site Trial,” which examined treatment retention and continued
The Substance Abuse and Mental Health Services Administration (SAMHSA) tracks many of the country’s events that recognize and celebrate the work of recovery. For more info:
The CODA Research team is currently working on another phase of the PROMIS project. PROMIS stands for “Patient Reported Outcomes Measurement Information System” and is funded by the National Institutes
Check out this new post about CODA on the United Way of the Columbia-Willamette blog!
CODA’s Portland Recovery Center is now the only medication-assisted treatment program in Portland to have earned the The Joint Commission’s Gold Seal of Approval®! This accreditation recognizes our dedication to
The Meyer Memorial Trust posted this story about CODA’s Stepping Stones housing.